European guidelines mention permethrin, benzyl benzoate and crotamiton as topical antiscabiosa. There have been repeated reports of treatment failure with permethrin in recent years, although the causes are controversial. In order to directly compare permethrin 5% with benzyl benzoate 25%, an Austrian research team conducted a double-blind randomized study.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- DERMATOLOGIE PRAXIS
Related Topics
You May Also Like
- Study report
Sphingolipid profile in early-stage primary biliary cholangitis
- Angiosarcoma of the heart
A diagnostic and therapeutic “black box”
- Ataxias
Friedreich’s ataxia: when the energy metabolism attacks the nervous system
- Risk of osteoporosis in autoimmune liver diseases
Always determine bone density in PBC, PSC and AIH
- Case report: Complication after type 2 diabetes
Topical corticosteroids lead to ketoacidosis
- NSCLC
Bispecific antibodies for rare EGFR mutations
- Type 2 diabetes - glycemic control and prevention of secondary diseases
Utilizing pleiotropic cardio- and nephroprotective effects of SGLT-2-i and GLP-1-RA
- Subsyndromal anxiety disorders: Family doctor as first point of contact